Study of the pharmacokinetics of levofloxacin when combined with st. John’s wort preparations in healthy volunteers and in patients with lower respiratory tract infection

Abstract

In patients with pneumonia and concomitant diseases, the administration of antimicrobial agents together with other medications accompanied by the risk of side effects and drug-drug interactions. We studied the pharmacokinetics (PK) of levofloxacin when combined with a herbal preparation (common St. John’s wort extract) in healthy volunteers and in patients with community-acquired pneumonia on the days 1 and 5 of the drugs intake. Individual differences in the average concentrations (AUC analog) of the antibiotic before and after the course of administration of the St. John’s wort extract within each group were quite significant; however, the group-average differences were statistically insignificant. Intergroup differences in PK with St. John’s wort intake were also statistically insignificant. To search for factors that make a significant contribution to the variations observed in PK indices, we used a statistical multivariate analysis of variance which included factors such as gender, age, body mass index, smoking history, and cardiovascular system parameters. We found that smoking only and, to a lesser extent, the patient’s gender had an effect on levofloxacin PK, while the intake of St. John’s wort completely eliminated this effect. Other factors played an insignificant role in the antibiotic PK regardless of the St. John’s wort administration.

Keywords

common St. John’s wort / levofloxacin / pneumonia / pharmacokinetics

References

[1] Alyautdin R.N., Guseynov M.D., Zil’fikarov I.N., Romanov B.K. Stress-protective herbal medicine. Biomeditsina. 2011;(3):115-9. (in Russian)

[2] Аляутдин Р.Н., Гусейнов М.Д., Зильфикаров И.Н., Романов Б.К. Стресс-протекторная фитотерапия. Биомедицина. 2011;(3):115-9.

[3] Vas’kova L.B., Lopatin P.V., Romanov B.K. Parmacoeconomics in pharmacy. [Farmakoekonomika v farmatsii]. Moscow: Izdatel’stvo Pervogo MGMU im. I.M.Sechenova; 2012. 188 p. (in Russian)

[4] Васькова Л.Б., Лопатин П.В., Романов Б.К. Фармакоэкономика в фармации. М.: Издательство Первого МГМУ им. И.М.Сеченова; 2012. 188 c.

[5] Kukes V.G., Grachev S.V., Sychev D.V., Ramenskaya G.V. Drug metabolism. The scientific basis of personalized medicine. A guide for doctors. [Metabolizm lekarstvennykh sredstv. Nauchnye osnovy personalizirovannoy meditsiny. Rukovodstvo dlya vrachey]. Moscow: Geotar-Media; 2008. 304 p. (in Russian)

[6] Кукес В.Г., Грачев С.В., Сычев Д.В., Раменская Г.В. Метаболизм лекарственных средств. Научные основы персонализированной медицины. Руководство для врачей. М.: Геотар-Медиа; 2008. 304 c.

[7] Sychev D.A., Otdelenov V.A., Denisenko N.P., Smirnov V.V. The study of the activity of isoenzymes of cytochrome P450 for the prediction of drug-drug interactions of medicines in terms of polypharmacy. Farmakogenetika i farmakogenomika. 2016;(2): 4-11. (in Russian)

[8] Сычёв Д.А., Отделенов В.А., Денисенко Н.П., Смирнов В.В. Изучение активности изоферментов цитохрома Р450 для прогнозирования межлекарственных взаимодействий лекарственных средств в условиях полипрагмазии. Фармакогенетика и фармакогеномика. 2016;(2):4-11.

[9] Chuchalin A.G., Sinopal’nikov A.I., Kozlov R.S., Tyurin I.E., Rachina S.A. Community-acquired pneumonia in adults: practical recommendations for diagnosis, treatment and prevention. Infektsionnye bolezni: novosti, mneniya, obuchenie. 2013;(2):91-123. (in Russian)

[10] Чучалин А.Г., Синопальников А.И., Козлов Р.С., Тюрин И.Е., Рачина С.А. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике. Инфекционные болезни: новости, мнения, обучение. 2013;(2): 91-123.

[11] Shikh E.V., Bulaev V.M., Demidova O.A. The safety assessment of medicinal plants. Bezopasnost’ i risk farmakoterapii. 2015;(2):23-9. (in Russian)

[12] Ших Е.В., Булаев В.М., Демидова О.А. Oценка безопасности лекарственных растений. Безопасность и риск фармакотерапии. 2015;(2):23-9.

[13] Gurley B.J., Swain A., Williams D.K., Barone G., Battu S.K. Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John’s wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics. Mol Nutr Food Res. 2008;52(7):772-9. Doi: 10.1002/mnfr.200700081.

[14] Hall S.D., Wang Z., Huang S.M., Hamman M.A., Vasavada N., Adigun A.Q. et al. The interaction between St John’s wort and an oral contraceptive. Clin Pharmacol Ther. 2003;74(6):525-35. Doi: 10.1016/j.clpt.2003.08.009.

[15] Wang Z., Gorski J.C., Hamman M.A., Huang S.M., Lesko L.J., Hall S.D. The effects of St John’s wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther. 2001; 70(4):317-26. Doi: 10.1016/s0009-9236(01)17221-8.

RIGHTS & PERMISSIONS

Eco-Vector